Dr. Jason Comander is a member of the Mass Eye and Ear Inherited Retinal Disorders Service and Retina Service, where he specializes in diagnosing and treating inherited retinal diseases. He is also a member of the Ocular Genomics Institute, the Berman-Gund Laboratory for Retinal Degenerations, and the Howe Laboratory.

As a clinician-scientist, Dr. Comander's research primarily focuses on the genetics and treatment of inherited retinal diseases. He has studied the genetic basis of distinct forms of retinitis pigmentosa, investigated methods to assay the functional significance of human mutations, and tested techniques for retinal gene therapy in primates.  He also is an investigator and surgeon for a number of ongoing clinical trials for patients with inherited retinal disorders.

A driven and industrious clinician with a demonstrated aptitude for research, Dr. Comander was selected to attend the Heed Foundation Retreat for Academic Ophthalmology in 2009. In 2012, he was recognized as an up-and-coming clinician scientist when he received the highly competitive K12 Mentored Clinical Scientist Development Program Award from the National Institutes of Health, to support his research on inherited retinal disorders. He also holds a Career Development Award from Research to Prevent Blindness and an Enhanced Career Development Award from the Foundation Fighting Blindness.

Clinical Interests

Inherited retinal disorders such as retinitis pigmentosa and Stargardt disease

Retinal disorders including macular degeneration, retinal detachment, macular hole, and epiretinal membrane